Earnings reports are critical outlets for information that biotech investors need to know about, so they can't be disregarded.
Biotech companies have a long lag between starting a project and getting revenue from it, so their earnings reports are often light on financial information.
For biotechs that do have a lot of financial information to report, investors may still want to focus more on other factors.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,